Sublingual Sprays Market Segmented By drug class such as Antianginal agents, Vasodilators, Calcium channel blocking agents, Group IV antiarrhythmics, Vitamin and mineral combinations in Unit dose spray and Bidose spray form
Industry: Healthcare
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Report Type: Ongoing
Report ID: PMRREP17725
Sublingual is medication administration technique of providing medication through mouth. Sublingual drugs involve tablets, films and sprays. The administration method involve the placement of drug under the tongue that is dissolved and absorbed by tissues. Sublingual spray contains vigorous ingredient suspended in liquid form which is directly absorbed into the blood streams.
These devices are used for sleep aids, vaccines, pain management and vitamin deficiency. Sublingual sprays are effective, quick and safe medical administration method among all the existing methods involving oral, buccal or injections. Sublingual spray are the drugs developed for the patients having trouble in swallowing medication, improper absorption of medication in stomach, due to the diminishing effect of drug with digestion or when the quick medication is required. Sublingual sprays are mostly prescribed to the patients having chronic cancer disease. Sublingual sprays help in boosting the immune system quickly to support the medical conditions.
The continuous research in the sublingual type administration method drives the sublingual spray market globally. This drug delivery is auspicious owing to non-invasive, feasible systemic delivery type that fuel the global market of sublingual spray. With the ease of administration and enhanced compliance facility associated with the drug offers the advantage to patient and physician over the invasive and oral medication is anticipated to drive the market in the forecast.
Moreover, presence of open sores in mouth, effect of drinking, eating or smoking on the sublingual medication is detrimental, and are the factors restraining the growth of global sublingual market. When the slow processing of drug is required by the patient, sublingual administration method do not work well, eventually, limit the market growth.
The global sublingual spray market is classified on the basis of drug class, distribution channel and geography.
|
Based on drug class |
|
| Based on distribution channel |
|
| Based on form |
|
| Based on geography |
|
The increasing focus of government and public organization to satisfy the unmet need of CNS disease involves use of sublingual medication administration methods. The disorders such as depression, schizophrenia, migraine, insomnia, Alzheimer’s disease, Parkinson’s disease, attention deficit hyperactivity disorder, bipolarism and anxiety disorders require non-invasive medication delivery and unit dose and bidose approach have been very beneficial. The global sublingual spray market is anticipated to show a significant growth over the forecast period owing to the increasing demand of these type of medication administration.
By distribution channel, the global sublingual spray market has been segmented into hospitals pharmacies, private clinics, drug stores, retail pharmacy and E-commerce.
Based on geography, global sublingual spray market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America is the most eye-catching sublingual spray market due to increasing prevalence of cancer diseases.
The better availability of healthcare facilities, reimbursement scenario and skilled professionals makes North America dominate the sublingual spray market over the globe. Europe is projected to hold the second largest market share in global sublingual spray market. The sublingual spray market in Asia Pacific and Middle East regions are projected to grow fast owing to the increased government funds and focus on better healthcare facilities.
Some leading key players in the global market of sublingual spray are as Perrigo Company plc, Insys Therapeutics, Ltd., Sun Pharmaceutical Industries Ltd., Mist Pharmaceuticals., NovaDel Pharma Inc., Generex Biotechnology Corp., GW Pharmaceuticals, plc., Europlaz Technologies and Piramal Enterprises Ltd.
The report covers exhaustive analysis on:
To know more about delivery timeline for this report Contact Sales
